You are a seasoned investor. Do you invest based on price signals or your own knowledge? I agree that expenses are out of control right now and the market is extrapolating that that will continue forever. They can always cut costs later. Daxxify is not over hyped. It's the real deal. Eventually it will take major market share.
I agree that expenditures are very high given the sales revenue. Perhaps my personal expectations were too lofty ($27.5 M) and should have considered differently.
PDUFA date for sBLA in CD will prove to be an interesting experience for us all as we watch this story unfold. I suspect we will see another sell off after the FDA approval (should it take place). Seemingly companies getting the FDA nod are getting hammered hard after the announcement. Perhaps the big investment firms are shorting the heck out of companies like RVNC? Not sure about much these days sir.
How much should they be spending? A large chunk of the spend should be thought of as "investments"... Building relationships, training & education, etc., which will turn into revenues / returns over time.
News 
Market Data 
Discover 
